Market Cap 58.26M
Revenue (ttm) 22.36M
Net Income (ttm) -41.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -186.54%
Debt to Equity Ratio 0.45
Volume 33,000
Avg Vol 14,054
Day's Range N/A - N/A
Shares Out 7.30M
Stochastic %K 92%
Beta 1.09
Analysts Sell
Price Target $10.50

Company Profile

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a b...

Industry: Health Information Services
Sector: Healthcare
Address:
322 W. 57th Street, New York, United States
DCA1120
DCA1120 May. 13 at 11:56 AM
$DRIO $DRIO just posted a solid beat: Revenue of $5.6M topped estimates, EPS beat by 23¢, expenses down 21%, and operating loss improved 22%. Sequential revenue growth for the 2nd straight quarter, cash burn trending lower, and strong momentum in their B2B2C pipeline. Bullish setup.
1 · Reply
DCA1120
DCA1120 May. 13 at 11:55 AM
$DRIO just posted a solid beat: Revenue of $5.6M topped estimates, EPS beat by 23¢, expenses down 21%, and operating loss improved 22%. Sequential revenue growth for the 2nd straight quarter, cash burn trending lower, and strong momentum in their B2B2C pipeline. Bullish setup.
0 · Reply
rapidtrades
rapidtrades May. 13 at 11:45 AM
$DRIO holding strong
0 · Reply
Torn891
Torn891 May. 13 at 11:11 AM
$DRIO the land of broken promises.
0 · Reply
focafoca99
focafoca99 May. 13 at 10:49 AM
$DRIO shows Q1 2026 revenue of $5.6M and a narrowed operating loss as it scales its digital health platform.
0 · Reply
CalciumNitrate
CalciumNitrate May. 13 at 10:49 AM
$DRIO revenue up, expenses down, but no mention of when they expect to break even, and the press release was kind of just blah, here-are-the-numbers kind of PR.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 13 at 10:15 AM
$DRIO Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $1.25 down -56.45% YoY • Reported revenue of $5.58M down -17.30% YoY
0 · Reply
rapidtrades
rapidtrades May. 12 at 6:23 PM
$DRIO get ready for $10
0 · Reply
rapidtrades
rapidtrades May. 12 at 5:09 PM
$DRIO bouncing back up👆
0 · Reply
STCG
STCG May. 12 at 4:22 PM
$DRIO Had around 100 random shares from an old bid I forgot to cancel that filled. Sold at 8.43 or so. No shares into earnings. Increases before earnings are always better than the drops where "someone know something". I'm watching and hoping for a great day for the bulls on here.
0 · Reply
Latest News on DRIO
DarioHealth trading resumes

2026-04-08T17:00:51.000Z - 4 weeks ago

DarioHealth trading resumes


DarioHealth trading halted, volatility trading pause

2026-04-08T16:55:48.000Z - 4 weeks ago

DarioHealth trading halted, volatility trading pause


DarioHealth price target lowered to $10 from $16 at Stifel

2026-03-20T11:45:54.000Z - 7 weeks ago

DarioHealth price target lowered to $10 from $16 at Stifel


DarioHealth files $100M mixed securities shelf

2026-03-19T21:05:39.000Z - 7 weeks ago

DarioHealth files $100M mixed securities shelf


DarioHealth Earnings Call Transcript: Q4 2025

Mar 19, 2026, 8:30 AM EDT - 7 weeks ago

DarioHealth Earnings Call Transcript: Q4 2025


DarioHealth reports  Q4 revenue $5.2M, consensus $5.05M

2026-03-19T10:41:17.000Z - 7 weeks ago

DarioHealth reports Q4 revenue $5.2M, consensus $5.05M


DarioHealth announces 79 new accounts signed year-to-date

2025-12-02T13:05:34.000Z - 5 months ago

DarioHealth announces 79 new accounts signed year-to-date


DarioHealth price target raised to $11 from 60c at TD Cowen

2025-11-14T13:50:25.000Z - 6 months ago

DarioHealth price target raised to $11 from 60c at TD Cowen


DarioHealth Earnings Call Transcript: Q3 2025

Nov 13, 2025, 8:30 AM EST - 6 months ago

DarioHealth Earnings Call Transcript: Q3 2025


DarioHealth reports Q3 EPS ($2.96), consensus ($2.42)

2025-11-13T11:41:04.000Z - 6 months ago

DarioHealth reports Q3 EPS ($2.96), consensus ($2.42)


DarioHealth signs six new employer clients to portfolio

2025-10-13T12:40:47.000Z - 7 months ago

DarioHealth signs six new employer clients to portfolio


DarioHealth, OneStep announce strategic collaboration

2025-10-06T11:36:27.000Z - 7 months ago

DarioHealth, OneStep announce strategic collaboration


DarioHealth trading halted, news pending

2025-08-27T23:50:14.000Z - 9 months ago

DarioHealth trading halted, news pending


DarioHealth announces 20-to-1 reverse stock split

2025-08-25T12:05:47.000Z - 9 months ago

DarioHealth announces 20-to-1 reverse stock split


DarioHealth Announces 20-to-1 Reverse Stock Split

Aug 25, 2025, 8:00 AM EDT - 9 months ago

DarioHealth Announces 20-to-1 Reverse Stock Split


DarioHealth Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 9 months ago

DarioHealth Earnings Call Transcript: Q2 2025


DarioHealth Earnings Call Transcript: Q1 2025

May 14, 2025, 8:30 AM EDT - 1 year ago

DarioHealth Earnings Call Transcript: Q1 2025


DarioHealth Announces CFO Transition

Apr 21, 2025, 8:30 AM EDT - 1 year ago

DarioHealth Announces CFO Transition

BNRG


/C O R R E C T I O N -- DarioHealth Corp./

Mar 17, 2025, 8:30 AM EDT - 1 year ago

/C O R R E C T I O N -- DarioHealth Corp./


DarioHealth Earnings Call Transcript: Q4 2024

Mar 10, 2025, 8:30 AM EDT - 1 year ago

DarioHealth Earnings Call Transcript: Q4 2024


DCA1120
DCA1120 May. 13 at 11:56 AM
$DRIO $DRIO just posted a solid beat: Revenue of $5.6M topped estimates, EPS beat by 23¢, expenses down 21%, and operating loss improved 22%. Sequential revenue growth for the 2nd straight quarter, cash burn trending lower, and strong momentum in their B2B2C pipeline. Bullish setup.
1 · Reply
DCA1120
DCA1120 May. 13 at 11:55 AM
$DRIO just posted a solid beat: Revenue of $5.6M topped estimates, EPS beat by 23¢, expenses down 21%, and operating loss improved 22%. Sequential revenue growth for the 2nd straight quarter, cash burn trending lower, and strong momentum in their B2B2C pipeline. Bullish setup.
0 · Reply
rapidtrades
rapidtrades May. 13 at 11:45 AM
$DRIO holding strong
0 · Reply
Torn891
Torn891 May. 13 at 11:11 AM
$DRIO the land of broken promises.
0 · Reply
focafoca99
focafoca99 May. 13 at 10:49 AM
$DRIO shows Q1 2026 revenue of $5.6M and a narrowed operating loss as it scales its digital health platform.
0 · Reply
CalciumNitrate
CalciumNitrate May. 13 at 10:49 AM
$DRIO revenue up, expenses down, but no mention of when they expect to break even, and the press release was kind of just blah, here-are-the-numbers kind of PR.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 13 at 10:15 AM
$DRIO Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $1.25 down -56.45% YoY • Reported revenue of $5.58M down -17.30% YoY
0 · Reply
rapidtrades
rapidtrades May. 12 at 6:23 PM
$DRIO get ready for $10
0 · Reply
rapidtrades
rapidtrades May. 12 at 5:09 PM
$DRIO bouncing back up👆
0 · Reply
STCG
STCG May. 12 at 4:22 PM
$DRIO Had around 100 random shares from an old bid I forgot to cancel that filled. Sold at 8.43 or so. No shares into earnings. Increases before earnings are always better than the drops where "someone know something". I'm watching and hoping for a great day for the bulls on here.
0 · Reply
rapidtrades
rapidtrades May. 12 at 3:24 PM
$DRIO $16 by tomorrow
0 · Reply
rapidtrades
rapidtrades May. 12 at 2:50 PM
$DRIO JOINED THE PARTY
0 · Reply
Bamapride88
Bamapride88 May. 12 at 7:32 AM
$DRIO 🙌
0 · Reply
STCG
STCG May. 7 at 2:30 PM
$DRIO one hour in and zero shares traded. it would be anticlimactic if they get bought out for $8.0 a share. if there is a dip before earnings, I might pick up some shares.
0 · Reply
SuperGreenToday
SuperGreenToday May. 6 at 8:24 PM
0 · Reply
CalciumNitrate
CalciumNitrate May. 5 at 9:20 PM
$DRIO been thinking about the new posts by the dario_health account. If Q1 revenue was bad (decline or flat compared to Q4_2025), then it's best to say nothing, rather than try to hype the stock with such posts, only to then disappoint people when earnings come out. If Q1 revenue was amazing, then again, best to say nothing, and surprise everyone. So I'm guessing revenue increased a little relative to last quarter, but they're basically saying "it'll get better this year". Anyone have any thoughts on this?
1 · Reply
CalciumNitrate
CalciumNitrate May. 4 at 3:40 PM
$DRIO earnings May 13
0 · Reply
dario_health
dario_health Apr. 30 at 4:32 PM
2026 is an execution year for $DRIO: rev ramping as 2025 deals convert, ~$13M in new contracted & late‑stage ARR (70%+ multi-condition), 28% YoY opex reduction, and a 13B+ data moat as payers consolidate to platforms that can prove ROI. Full interview: https://x.com/ST_BoardroomX/status/2049490291254579399?s=20
0 · Reply
Stocktwits
Stocktwits Apr. 29 at 3:47 PM
$DRIO DarioHealth is a digital health company transforming chronic condition management that delivers documented clinical outcomes and proven ROI for the world’s largest health plans and self-insured employers. President and CCO Steven Nelson discusses their record-breaking 2025 commercial performance, their expansion into 175M+ covered lives via channel partnerships, and how their proprietary clinical data moat is positioning their path to profitability.
3 · Reply
DCA1120
DCA1120 Apr. 29 at 3:20 PM
$DRIO https://www.uhc.com/news-articles/benefits-and-coverage/dario
1 · Reply
StreetwiseReports
StreetwiseReports Apr. 28 at 5:41 PM
New York Healthcare Technology Co. Discovers Scalable Behavioral Health Breakthrough https://ow.ly/83t750YReIl DarioHealth Corp.'s ( $DRIO ) study showed measurable workplace productivity and cognitive function improvements in 1,254 users within weeks, boosting growth potential.
0 · Reply
dario_health
dario_health Apr. 28 at 3:04 PM
Macro tailwinds for $DRIO: payers are now being held accountable for ROI and are cutting vendors that can’t prove cost savings or outcomes — pressure that’s real and accelerating. At the same time, the market is shifting from point solutions to multi‑condition platforms, exactly what Dario has built, putting it in the category that survives and wins as vendors consolidate.
1 · Reply